University of Utah, Clinical and Translational Sciences Institute

Salt Lake City, Utah 84108

2 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Glycogen Storage Disease Type II Infantile Onset, Pompe Disease (Late-onset)

Studies at this site

• A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18 — Recruiting now
• Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease — Recruiting now
• ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD — Running, not enrolling